Carroll Khristine L 4
4 · AdvanSource Biomaterials Corp · Filed Dec 6, 2019
Insider Transaction Report
Form 4
Carroll Khristine L
EVP of Commercial Operations
Transactions
- Exercise of In-Money
Common Stock
2019-12-05+600,000→ 1,335,309 total - Exercise of In-Money
Common Stock
2019-12-05$0.06/sh+100,000$6,000→ 385,309 total - Exercise of In-Money
Common Stock
2019-12-05+350,000→ 735,309 total
Footnotes (3)
- [F1]Shares acquired through the exercise of options granted pursuant to the 2003 Stock Option Plan at an exercise price of $0.06 per share in consideration of cash.
- [F2]Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 500,000 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 350,000 shares, net.
- [F3]Shares acquired from the exercise of options granted pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 750,000 shares of the Company's common stock at an exercise price of $0.04 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 600,000 shares, net.